Hepatocellular Carcinoma with Indolent T-lymphoblastic Proliferation.

Zhao-Ming Wang,Wen-Bo Xiao,Shu-Sen Zheng,Ke Sun,Li-Jun Wang

DOI: https://doi.org/10.1080/10428190600822151

2006-01-01

Abstract:Terminal deoxynucleotidyl transferase (TdT) labels a population of immature bone marrow T and B lymphocytes that comprise approximately 2% of the normal adult marrow population, and all early and c...

What problem does this paper attempt to address?

Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Mei Kong,Zhaoming Wang,Xiaodong Teng,Liming Xu,Jimin Liu,Chaozhe Jiang,Lisong Teng

2018-01-01

Abstract:Although indolent T-lymphoblastic proliferation (iT-LBP) in the extrathymic location have been shown to be a distinct clinicopathologic entity, carcinoma composed iT-LBP are rare. We retrospectively analyzed the clinicopathological features of 7 hepatic carcinoma cases with iT-LBP. There were 5 male and 2 female patients, aged from 37-54 (mean 47) years. All patients had a clinical history of chronic hepatitis B viral infection with high serum AFP level. Microscopically, these carcinomas were characterized by admixed with increased amounts of fibrous and small lymphocytes composed of regressive germinal centers. Immunohistochemically, in lymphoid tissues, some TDT+ cells were highlighted in the CD3+ area. These lymphoblasts localized predominantly between the cords of the carcinoma and interfollicular regions, diffused or only focal presented more than 50 TdT+ lymphoblasts/HPF. No EBV infection cells and T-cell antigen clonal rearrangement was detected. 3/4 cirrhotic patients developed HCC recurrence, while the 4-y survival rate was 100% in non-cirrhosis patients. It-LBP is a rare unusual proliferation and easily be misdiagnosed in HC patients. It does not seem to be associated with a specific HCC type. If HC companied with numerous small lymphocytes infiltration and showed high Ki67 index, a primary HC with iT-LBP should be considered in the lists of diagnosis.
Retrospective Study On T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding And Survival.

Hongyan Tong,Feng Xiao,Tieying Dai,Jie Jin,Haitao Meng,Wenbing Qian,Wenyuan Mai,Fengjuan Zhang,Hui Liu

DOI: https://doi.org/10.1182/blood.v108.11.4652.4652

IF: 20.3

2006-01-01

Blood

Abstract:T-cell lymphoma is the special malignant type of non-Hodgkin's lymphoma. The diagnosis and the treatment were usually troublesome for physician in clinical practice. We retrospectively reviewed 63 cases of T-cell lymphomas from 360 cases of lymphomas in our hospital during the period from January 2000 to July 2006. This study is to determine the clinicopathological characteristics of T cell lymphomas. The patients were reclassified according to the World Health Organization classification system. Clinical data, including age, gender, clinical staging, and follow-up, were scrutinized.
Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Mei Kong,Zhaoming Wang,Xiaodong Teng,Liming Xu,Jimin Liu,Chenyang Jiang,Lisong Teng

2019-01-01

Abstract:[This corrects the article on p. 1674 in vol. 11, PMID: 31938268.].
Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report

Wen Han,Bei Wang,Xiang Yong,Yi Zhang,Mingyu Shao,Chun Wang

DOI: https://doi.org/10.3389/pore.2023.1611151

2023-05-12

Abstract:Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells. Isolated iT-LBP has been observed, but the majority of iT-LBP cases has been seen in conjunction with other diseases. iT-LBP is easily misdiagnosed as T-lymphoblastic lymphoma/leukemia, and understanding the disease of indolent T-lymphoblastic proliferation may prevent misdiagnosis and missed diagnosis in pathological diagnosis. Case presentation: We report a case morphology, immunophenotypic, and molecular features of iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma and review relevant literature. Conclusion: iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma is relatively rare and should always be considered as a differential diagnosis of T-lymphoblastic lymphoma and scirrhous hepatocellular carcinoma as the two disorders show highly similar clinical features.

oncology,pathology
Uterine Leiomyoma With Indolent B-Lymphoblastic Proliferation

Zhaoming Wang,Ke Sun,Wenbo Xiao

2013-01-01

Abstract:Uterine leiomyoma with TdT positive B lymphocytes infiltrating is very rare and may simulate precursor B-cell lymphoblastic lymphoma (B-LBL). To the best of our knowledge, this is the first description of such a lesion in English literature. A 51-year-old Chinese woman was noted a mass in her uterus in a routine physical examination. The myomectomy specimen was identified as a well-defined 8.0x6.8 cm tumor and the cut surface was fresh and yellow-tan. A massive small lymphocytic infiltration accompanied by plasma cells and histiocytes was noted in the leiomyoma but not in the surrounding non-neoplastic myometrial fibers. These cells were small in size without significant nuclear irregularities and mitotic figures can not been seen. Immunohistochemical analysis has shown some small lymphocytes were CD20+, CD79a+, Pax5+B cells and some were CD2+, CD3+, CD5+, CD43+ T cells. The small B cells coexpressed TdT and Ki67 and were in patchy dense distribution. The postoperative course was uneventful within a 30-month follow-up period without chemotherapy and radiotherapy. The true nature of these TdT(+) B cells has not been determined.
Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia|[sol]|lymphoma

Yi Zhou,Xiangshan Fan,mark j routbort,cheng cameron yin,Rajesh Singh,carlos e buesoramos,Deborah A Thomas,Denái R Milton,L Jeffrey Medeiros,Pei Lin

DOI: https://doi.org/10.1038/modpathol.2013.78

IF: 8.209

2013-01-01

Modern Pathology

Abstract:Terminal deoxynucleotidyl transferase (TdT) can be downregulated in minimal residual disease of T-acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) after chemotherapy. TdT-negative T-ALL/LBL cases are rare and have not been well characterized. We studied the clinicopathologic features of de novo T-ALL/LBL patients treated at our institution during 2003–2011, with an emphasis on immunophenotype and survival of TdT-negative versus TdT-positive cases. Absence of TdT expression was defined as <10% lymphoblasts positive. Seven (12%) TdT-negative cases were identified from a cohort of 59 de novo T-ALL/LBL. The TdT-negative and TdT-positive cases were similar with regard to gender, percentage of patients with a high leukocyte count (>100 × 109/l), central nervous system involvement, and an abnormal karyotype. However, patients with TdT-negative T-ALL/LBL had a significantly higher rate of disease progression and shorter overall survival. Although not statistically significant, TdT-negative T-ALL/LBL cases were associated with an older median age and higher percentage of ‘early T precursor’ (ETP) immunophenotype than TdT-positive cases. Absence of TdT expression identifies a subset of high-risk T-ALL/LBL that overlaps with, but is not identical to, the ETP leukemia, providing additional prognostic value.
Lymphoma-Like T Cell Infiltration In Liver Is Associated With Increased Copy Number Of Dominant Negative Form Of Tgf Beta Receptor Ii

Weici Zhang,Masanobu Tsuda,Guo-Xiang Yang,Koichi Tsuneyama,Xiao-Song He,Aftab A. Ansari,William M. Ridgway,Ross L. Coppel,Zhe-Xiong Lian,Patrick S. C. Leung,M. Eric Gershwin

DOI: https://doi.org/10.1371/journal.pone.0049413

IF: 3.7

2012-01-01

PLoS ONE

Abstract:Hepatosplenic T cell lymphoma (HSTCL) is a distinct and lethal subtype of peripheral T cell lymphoma with an aggressive course and poor outcome despite multiagent chemotherapy. Contradictory literature, an unknown etiology, and poor response to treatment highlight the need to define the malignant process and identify molecular targets with potential for successful therapeutic interventions. Herein, we report that mice homozygously expressing a dominant negative TGF beta RII (dnTGF beta RII) under the control of the CD4 promoter spontaneously develop lymphoma-like T cell infiltration involving both spleen and liver. Splenomegaly, hepatomegaly and liver dysfunction were observed in homozygous dnTGFbRII mice between 10 weeks and 10 months of age associated with a predominant infiltration of CD4(-)CD8(-)TCR beta(+)NK1.1(+) or CD8(+)TCR beta(+)NK1.1(-) T cell subsets. Notch 1 and c-Myc expression at the mRNA levels were significantly increased and positively correlated with the cell number of lymphoid infiltrates in the liver of dnTGFbRII homozygous compared to hemizygous mice. Further, 2 x 10(4) isolated lymphoma-like cells transplant disease by adoptive cell transfers. Collectively, our data demonstrate that increased copy number of dnTGF beta RII is critical for development of lymphoma-like T cell infiltration.
[A Clinicopathological Study of 96 Cases of Lymphoblastic Lymphoma].

Yun Pan,Wei-Ping Liu,Jin-Fan Li,Wen-Yan Zhang,Feng-Yuan Li,Xiao-Xi Lu,Dan Li,Gan-di Li

DOI: https://doi.org/10.3760/j:issn:0253-2727.2005.04.007

2005-01-01

Abstract:OBJECTIVE:To investigate the clinicopathological and immunohistochemical features of lymphoblastic lymphoma (LBL).METHODS:A retrospective clinicopathological study of 96 cases LBL was carried out. Immunohistochemical staining was used for the characterization and immunophenotyping.RESULTS:The patients age ranged from 4 to 72 years, with a median of 16 years, 69 patients were male and 27 female. Seventy-three cases had superficial or multi-lymphoadenopathy and 31 of them had mediastinal masses. Bone marrow was involved in 15 cases. Seventy-three cases were in clinical stages III and IV. The median survival of the followed-up patients was 5.5 (2 approximately 120) months. TdT and CD99 positive reactions were 75.0% and 92.7%, respectively. Of the 96 cases, 78 displayed T-cell marker positivity and 18 B-cell markers. 82.1% of the patients younger than 30 years of age had significantly higher incidences of T-LBL (64 patients), and 93.6% of the patients with mediastinal masses expressed T-cell markers. The poor prognostic factors were T-cell tumors, clinical stages III and IV, Ki-67 PI < 80% and no chemotherapy (P < 0.01).CONCLUSION:In children and young males, mediastinal masses with superficial or multi-lymphoadenopathy favors the diagnosis of LBL, but negative TdT reaction can not exclude this diagnosis. T-LBL is more common than B-LBL. Clinical stages, immunophenotypes and the level of Ki-67 expression were closely related with prognosis of LBL.
Terminal Deoxynucleotidyl Transferase Negative T-cell Lymphoblastic Lymphoma from Heterotopic Warthin's Tumor in Cervical Lymph Nodes: a Case Report and Review of Literature.

Xubo Pan,Shengqiang Yu,Lisha Che,Jie Xu,Huihui Zhou

2019-01-01

Abstract:Collision of lymphoma and Warthin's tumor (WT) is extremely uncommon, especially T-cell lymphoma. Here we present a 69-year-old woman who had terminal deoxynucleotidyl transferase (TDT) negative T-cell lymphoblastic lymphoma (T-LBL) from heterotopic Warthin's tumor in cervical lymph nodes, in which only cervical lymph nodes enlarged initially and quickly progressed to systemic lesions.
Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma

Yi Zhou,Xiangshan Fan,Mark Routbort,C Cameron Yin,Rajesh Singh,Carlos Bueso-Ramos,Deborah A Thomas,Denái R Milton,L Jeffrey Medeiros,Pei Lin

DOI: https://doi.org/10.1038/modpathol.2013.78

IF: 8.209

2013-01-01

Modern Pathology

Abstract:Terminal deoxynucleotidyl transferase (TdT) can be downregulated in minimal residual disease of T-acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) after chemotherapy. TdT-negative T-ALL/LBL cases are rare and have not been well characterized. We studied the clinicopathologic features of de novo T-ALL/LBL patients treated at our institution during 2003–2011, with an emphasis on immunophenotype and survival of TdT-negative versus TdT-positive cases. Absence of TdT expression was defined as <10% lymphoblasts positive. Seven (12%) TdT-negative cases were identified from a cohort of 59 de novo T-ALL/LBL. The TdT-negative and TdT-positive cases were similar with regard to gender, percentage of patients with a high leukocyte count (>100 × 10 9 /l), central nervous system involvement, and an abnormal karyotype. However, patients with TdT-negative T-ALL/LBL had a significantly higher rate of disease progression and shorter overall survival. Although not statistically significant, TdT-negative T-ALL/LBL cases were associated with an older median age and higher percentage of ‘early T precursor’ (ETP) immunophenotype than TdT-positive cases. Absence of TdT expression identifies a subset of high-risk T-ALL/LBL that overlaps with, but is not identical to, the ETP leukemia, providing additional prognostic value.
Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia

Matthew M. Klairmont,Yinmei Zhou,Cheng Cheng,Ching-Hon Pui,Sima Jeha,Tanja A. Gruber,Yiwei Liu,Hiroto Inaba,John Kim Choi

DOI: https://doi.org/10.1038/s41379-021-00853-3

IF: 8.209

2021-06-19

Modern Pathology

Abstract:Little is known about B-lymphoblastic leukemia (B-ALL) that lacks expression of terminal deoxynucleotidyl transferase (TdT). To address this, we performed the largest study to date of TdT-negative B-ALL using data from St. Jude Total XV and XVI clinical trials. Compared to TdT-positive B-ALL (n = 896), TdT-negative B-ALL (n = 21) was associated with younger age (median, 1.4 versus 6.8 years, P < 0.001), higher white blood cell count (median, 52.8 versus 9.9 × 109/L, P < 0.001), absence of hyperdiploidy (0 versus 27.8%, P = 0.002), KMT2A rearrangement (100 versus 1.9%, P < 0.001), and inferior 5-year event-free survival (EFS) (76.2 versus 90.3%, P = 0.047). In the context of KMT2A-rearranged B-ALL (n = 38), TdT-negativity was significantly associated with the MLLT1 rearrangement partner (P = 0.026) but was not independently predictive of survival, suggesting that the high-risk features of TdT-negative B-ALL are secondary to underlying KMT2A rearrangements. Finally, we compared the sensitivity of TdT-negativity to neuron-glial antigen 2 (NG.2) expression for the detection of KMT2A rearrangements and found that 63% of KMT2A-rearranged B-ALL cases not identified by NG.2 were TdT-negative. The results of this study expand the spectrum of immunophenotypic features that are specific for high-risk KMT2A rearrangements in pediatric B-ALL and can be readily implemented using existing standard acute leukemia flow cytometry panels.

pathology
Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia

Chih-Hsiang Yu,Ying-Hui Su,Shiann-Tarng Jou,Meng-Yao Lu,Chien-Yu Lin,Kai-Hsin Lin,Hsiu-Hao Chang,Shu-Wei Chou,Ya-Hui Huang,Dong-Tsamn Lin,Shu-Wha Lin,Hsuan-Yu Chen,Ya-Hsuan Chang,Yung-Li Yang

DOI: https://doi.org/10.1016/j.prp.2024.155287

IF: 3.309

2024-04-03

Pathology - Research and Practice

Abstract:The lack of expression of terminal deoxynucleotidyl transferase (TdT) is frequently associated with KMT2A -rearranged subtype of pediatric acute lymphoblastic leukemia (ALL). However, this association has not been investigated extensively in the Asian population. A retrospective analysis of TdT expression in pediatric B-cell ALL (B-ALL) was performed in patients treated using the Taiwan Pediatric Oncology Group (TPOG) ALL 2002 and 2013 protocols. Among the 331 patients with B-ALL, 12 patients showed TdT negativity at initial diagnosis. Among these, eight patients showed KMT2A rearrangement (66.7%). Other patients showing negative TdT expression had ETV6::RUNX1 , MEF2D- rearranged, and other B-ALL subtypes. However, in the context of KMT2A -rearranged B-ALL (n = 20), only eight patients showed TdT negativity. The 5-year event-free survival and overall survival of patients with and without TdT expression were 83.8% versus 46.8% (P <0.001) and 86.3% versus 55.4% (P = 0.004), respectively. Moreover, several aberrant markers, such as CD2, CD56, CD7, and CD117, were rarely expressed in the B-ALL samples, and if expressed, they were enriched in specific genetic subtypes. The results of this study indicate that immunophenotypic features are correlated with specific genetic subtypes of childhood B-ALL.

pathology
Hepatic involvement by T-cell neoplasms: a clinicopathologic study of 40 cases

Philippa Li,Dongwei Zhang,Jiehao Zhou,Peng Li,Yulei Shen,Zenggang Pan,Andrew G Evans,Xiaoyan Liao,Andrew G. Evans

DOI: https://doi.org/10.1016/j.humpath.2020.09.007

IF: 3.526

2020-12-01

Human Pathology

Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Summary</h2>Hepatic involvement by a T-cell neoplasm is rare and often challenging to diagnose in liver biopsies. We collected 40 cases of T-cell neoplasms diagnosed in the liver from five large academic institutions to assess the clinicopathologic features. The patients included 11 females and 29 males, with a median age of 54 (range 2-75) years and a high mortality rate (31/37, 83.8%). Fourteen (35%) patients were diagnosed with hepatosplenic T-cell lymphoma (HSTCL), 13 (32.5%) peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), and 13 (32.5%) other types of T-cell neoplasms. Patients with HSTCL were much younger and had worse survival than PTCL-NOS and other T-cell neoplasms (P<0.05). On imaging studies, 20 cases (50%) showed abnormalities, including 10 with mass lesions that correlated with normal or cholestatic pattern enzyme elevation. Histomorphological analysis revealed four main patterns; with the exception of mass forming lesions (pattern 4; n=8), cases with sinusoidal predominant (pattern 1; n=12), portal predominant with sinusoidal infiltrates (pattern 2; n=13) or lobular aggregates (pattern 3; n=5) demonstrated small to medium lymphocytes resembling a reactive/inflammatory process. In addition, we described two cases of T-cell large granular lymphocytic leukemia that mimicked HSTCL, and a case of aggressive post-transplant lymphoproliferative disorder that developed after chronic EBV infection, suggesting the importance of EBV testing in some lymphoma cases. As the largest cohort of T-cell neoplasms in liver, our study provides critical data on disease frequency, distribution, and clinicopathologic features that are essential for accurate diagnosis.

pathology
An Unusual Primary Hepatic Lymphoma.

Jiong-Jie Yu,Wen-Tao Yan,Chao Li,Tian Yang

DOI: https://doi.org/10.1016/j.dld.2018.02.016

2018-01-01

Abstract:A 34-year-old man with a history of hepatitis B virus infection complained of right upper abdominal pain of one month's duration. Laboratory tests for HBsAg, HBeAb and HBcAb were positive while that for HBV-DNA was negative. In the serum tumour marker tests, levels of alpha-fetoprotein and carcinoembryonic antigen were normal and carbohydrate antigen 19–9 was elevated (66.6 U/mL). Abdominal computed tomography (CT) scanning revealed a 5.9 cm × 3.5 cm hypodense liver tumour (Fig. 1). This patient underwent hepatectomy (Fig. 2A) . We found diffuse lymphocytic infiltration by pathologic examinations (Fig. 2B) and immunohistochemistry staining shows positive results for CD20, CD79a, bcl-2 (Fig. 2C–E) and Ki-67 (>90%). At last, the patient was diagnosed with B-cell lymphoma and received chemotherapy for 6 cycles using rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP). During the one-year follow-up, the patient was disease-free and received no more additional therapy. Fig. 2(A) Postoperative gross specimen; (B) Histopathological section of the liver mass showing diffuse lymphocytic infiltration; (C) Positive CD20 stain; (D) Positive CD79a stain; (E) Positive bcl-2 stain. View Large Image Figure Viewer Download Hi-res image
Absence of Terminal Deoxynucleotidyl Transferase Expression in T-ALL/LBL Accumulates Chromosomal Abnormalities to Induce Drug Resistance

Hui Xiao,Siqi Wang,Yuejia Tang,Shanshan Li,Yufeng Jiang,Yi Yang,Yinwen Zhang,Yali Han,Xiaoyu Wu,Liang Zheng,Yanxin Li,Yijin Gao

DOI: https://doi.org/10.1002/ijc.34465

2023-01-01

International Journal of Cancer

Abstract:T-acute lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a malignant neoplasm of immature lymphoblasts. Terminal deoxynucleotidyl transferase (TDT) is a template-independent DNA polymerase that plays an essential role in generating diversity for immunoglobulin genes. T-ALL/LBL patients with TDT- have a worse prognosis. However, how TDT- promotes the disease progression of T-ALL/LBL remains unknown. Here we analyzed the prognosis of T-ALL/LBL patients in Shanghai Children's Medical Center (SCMC) and confirmed that TDT- patients had a higher rate of recurrence and remission failure and worse outcomes. Cellular experiments demonstrated that TDT was involved in DNA damage repair. TDT knockout delayed DNA repair, arrested the cell cycle and decreased apoptosis to induce the accumulation of chromosomal abnormalities and tolerance to abnormal karyotypes. Our study demonstrated that the poor outcomes in TDT- T-ALL/LBL might be due to the drug resistance (VP16 and MTX) induced by chromosomal abnormalities. Our findings revealed novel functions and mechanisms of TDT in T-ALL/LBL and supported that hematopoietic stem cell transplantation (HSCT) might be a better choice for these patients.
T-PLL Presenting with an Indolent Course

Arsa Thammahong,Narittee Sukswai,Chantana Polprasert

DOI: https://doi.org/10.1155/2024/7310135

2024-07-24

Abstract:T-cell prolymphocytic leukemia (T-PLL) is a rare, mature T-cell leukemia which usually presents with aggressive behavior. We report an asymptomatic T-PLL patient diagnosed by clinical features, lymphocyte morphology, and flow cytometry. Incidentally, she was found to have lymphocytosis and lymphadenopathy. Flow cytometry from blood revealed an abnormally increased CD4+ T-cell population. T-cell receptor clonality assessment by next-generation sequencing revealed a dominant clone in the ß-chain constant region. No pathogenic mutations in 25 lymphoma-related genes were found. Due to her asymptomatic T-PLL disease, we observed her clinical situation and blood count every three months for at least one year.
Indolent T-cell Lymphoproliferative Disease with Synchronous Diffuse Large B-cell Lymphoma

Linjie Guo,Zhonghui Wen,Xueying Su,Shuyuan Xiao,Yufang Wang

DOI: https://doi.org/10.1097/md.0000000000015323

IF: 1.6

2019-01-01

Medicine

Abstract:Rationale: Indolent T-cell lymphoproliferative disease (T-LPD) of gastrointestinal tract is a rare recently described disease that seldom progresses. We report a case of T-LPD with synchronous diffuse large B-cell lymphoma (DLBCL) that cause aggravation of disease. Patient concerns: A 46-year-old Chinese male presented with intermittent paraumbilical colic pain, bloating, and occasional diarrhea for 10 years. His condition aggravated with partial bowel obstruction recently. The patient was diagnosed as T-LPD initially based on histological result and T-cell receptor-gamma clonal gene rearrangement test. The patient was followed without chemotherapy. His condition stabilized for 1 year and then deteriorated with small intestine perforation. Diagnosis: The patient was diagnosed as indolent T-LPD and DLBCL finally. Interventions: The patient had surgery for intestine perforation and received chemotherapy for DLBCL and T-LPD afterward. Outcomes: At 6 months follow-up, the patient continued to have resolution of his symptoms. Lessons: Early detection of high-grade transformation of T-LPD or the coexistence of aggressive lymphoma is essential for the patient. DLBCL may coexist in the indolent course of T-LPD. The diagnosis of T-LPD should be made cautiously in case with progressing symptoms such as intestinal obstruction.
CD4 − /CD8 − Double-Negative Tumor-Infiltrating Lymphocytes Expanded from Solid Tumor Tissue Suppress the Proliferation of Tumor Cells in an MHC-independent Way

Jingyi Lu,Chen Huang,Rong He,Rongjia Xie,Yue Li,Xianling Guo,Qian Zhang,Qing Xu

DOI: https://doi.org/10.1007/s00432-023-04823-x

2023-01-01

Journal of Cancer Research and Clinical Oncology

Abstract:Tumor-infiltrating lymphocytes (TILs) have shown remarkable clinical responses in some patients with advanced solid tumors. As a rare subset of TILs, CD4−/CD8− double-negative T cells (DNTs) were poorly known. This study aims to investigate the characteristics and function of CD3+CD4−CD8− TILs (double-negative TIL, DN-TILs) derived from solid tumor. DN-TILs were derived and expanded ex vivo from resected gastric carcinoma tissue and phenotyped by flow cytometry. The cytotoxicity of DN-TILs was determined against established tumor cell lines in vitro or through in vivo adoptive transfer into xenograft models. K562 cells were transferred with the HLA gene to verify whether the cytotoxicity of DN-TILs was MHC-independent. Flow cytometric analysis revealed a high-purity population of DN-TILs (> 97
Phenotype and distribution of infiltrating lymphocytes in liver cancer tissues

SHI Jiong,DONG Qiongzhu,QIN Lunxiu,SUN Haijing,JIA Huliang

DOI: https://doi.org/10.3969/j.issn.1000-8179.20150297

2015-01-01

Chinese Journal of Clinical Oncology

Abstract:Objective:To identify the signature of tumor-infiltrating lymphocyte (TIL) subtypes that may affect cytokine expres-sion between different outcomes of hepatocellular carcinoma (HCC) patients by analyzing the CD molecular expression profiles of non-cancerous hepatic tissues. Methods:Surface markers of TIL in noncancerous hepatic tissues from 146 HCC patients were determined by using immunohistochemical method and flow cytometry. Univariate and multivariate Cox proportional hazards models and Kaplan-Meier method were used to analyze the association of their expression levels with tumor recurrence and survival. Results:More than 86.4%of TILs in patients were quiescent, as measured via CD4+or Foxp3 expression. Meanwhile, more than 90%of CD3+T cells ex-pressed CD8+. The proportion of T cells was low compared with CD8+T cells. The proportion of CD19 and CD20 in distant nontumor tissues almost was zero. The proportion of T cell subgroups isolated from HCC circulating whole blood did not show a significant shift compared with the normal control, as follows:CD4+T/CD8+T=1.167 ± 1.04, CD8+T/CD3+T=0.288 ± 0.116, and CD4+T/CD3+T=0.429 ± 0.178. The proportion of CD8+T cells in noncancerous hepatic tissues was higher than that in blood (P<0.001).Conclusion:TILs in HCC noncancerous hepatic tissues are increased and contain a subpopulation of CD3+CD8+T cells. CD8+T cells in cancerous tissues, rather than noncancerous tissues, show significant differences between different prognostic groups.
Terminal Plasmocytoid Differentiation of Malignant B Cells Induced by Autotumor-Reactive CD4+ T Cells in One Case of Splenic Marginal Zone B-cell Lymphoma

Thierry Bonnefoix,Jian-Qing Mi,Pascal Perron,Mary Callanan,Cosima Semoun,Mireille Favre,Jean-Charles Renversez,Marie-France Sotto,Dominique Leroux,Jean-Jacques Sotto

DOI: https://doi.org/10.1182/blood.v99.1.388

IF: 20.3

2002-01-01

Blood

Abstract:In lymphoid organs invaded by malignant B-cell lymphomas, the development of reactive CD4+ tumor-infiltrating T cells (TIL-T) at the contact of tumor cells is now firmly established.[1][1] [2][2] It has been reported that lymphoma B cells are capable of proliferating in response to various

Hepatocellular Carcinoma with Indolent T-lymphoblastic Proliferation.

Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Retrospective Study On T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding And Survival.

Erratum: Hepatic Carcinoma with Indolent T-lymphoblastic Proliferation (It-Lbp).

Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report

Uterine Leiomyoma With Indolent B-Lymphoblastic Proliferation

Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia|[sol]|lymphoma

Lymphoma-Like T Cell Infiltration In Liver Is Associated With Increased Copy Number Of Dominant Negative Form Of Tgf Beta Receptor Ii

[A Clinicopathological Study of 96 Cases of Lymphoblastic Lymphoma].

Terminal Deoxynucleotidyl Transferase Negative T-cell Lymphoblastic Lymphoma from Heterotopic Warthin's Tumor in Cervical Lymph Nodes: a Case Report and Review of Literature.

Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high-risk adult T-lymphoblastic leukemia/lymphoma

Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia

Terminal deoxynucleotidyl transferase expression in different subtypes of childhood B-cell acute lymphoblastic leukemia

Hepatic involvement by T-cell neoplasms: a clinicopathologic study of 40 cases

An Unusual Primary Hepatic Lymphoma.

Absence of Terminal Deoxynucleotidyl Transferase Expression in T-ALL/LBL Accumulates Chromosomal Abnormalities to Induce Drug Resistance

T-PLL Presenting with an Indolent Course

Indolent T-cell Lymphoproliferative Disease with Synchronous Diffuse Large B-cell Lymphoma

CD4 − /CD8 − Double-Negative Tumor-Infiltrating Lymphocytes Expanded from Solid Tumor Tissue Suppress the Proliferation of Tumor Cells in an MHC-independent Way

Phenotype and distribution of infiltrating lymphocytes in liver cancer tissues

Terminal Plasmocytoid Differentiation of Malignant B Cells Induced by Autotumor-Reactive CD4+ T Cells in One Case of Splenic Marginal Zone B-cell Lymphoma